Presentation by Dr. John Doyle, Market Access Practice Leader, from ISPOR 14th Annual International Meeting 2009 (International Society for Pharmacoeconomics and Outcomes Research) on “The Effects of NICE HTA on Drug Prescribing and Expenditures in the U.S.” During this presentation Dr. Doyle addresses impact of NICE health technology assessments on drug utilization and spending in the U.S.